Pascal Joly

Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)

R. Bergman, E. Sprecher, D. Zillikens, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology.

D. Murrell, L. Borradori, E. Antiga, 2024, Journal of the European Academy of Dermatology and Venereology : JEADV.

Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic

D. Zillikens, M. Yale, D. Murrell, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic

D. Zillikens, M. Yale, D. Woodley, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT

D. Murrell, M. Worm, E. Mortensen, 2024, Advances in therapy.